Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by liaudet-coopman
Group name EquipeELC
Item Type Journal Article
Title Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?
Creator Jacot et al.
Author William Jacot
Author Charles Theillet
Author Séverine Guiu
Author Pierre-Jean Lamy
Publication Future Oncology (London, England)
Volume 11
Issue 4
Pages 557-559
Date 2015
Journal Abbr Future Oncol
Language eng
DOI 10.2217/fon.14.268
ISSN 1744-8301
Short Title Targeting triple-negative breast cancer and high-grade ovarian carcinoma
Library Catalog PubMed
Extra PMID: 25686112
Tags 53BP1, Antineoplastic Agents, BRCA1, breast cancer, clinic, Female, Genes, BRCA1, Genes, BRCA2, Genomic Instability, Humans, Molecular Targeted Therapy, Mutation, Neoplasm Grading, Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, targeted therapies, Triple Negative Breast Neoplasms
Date Added 2018/09/26 - 14:32:39
Date Modified 2019/05/29 - 12:28:43


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés